Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Ferroptosis and cancer prognosis, and Cancer Immunotherapy and Biomarkers.
Induction of ferroptosis in prostate cancer by CCDC7<sub>19-13</sub> via TRIM21-mediated ubiquitination of SLC7A11.
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression.
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer.
The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer.
ANXA2-mediated Phagocytosis Generates AR<sup>+</sup> Macrophages to Confer Enzalutamide Resistance in Prostate Cancer.
Reinforcement Learning-Based Digital Therapeutic Intervention for Postprostatectomy Incontinence: Development and Pilot Feasibility Study.
Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer
Low-dimensional antimicrobial nanomaterials in anti-infection treatment and wound healing
Integrative analysis of cuproptosis-related lncRNAs: Unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancer
Profiling chimeric RNA in prostate cancer in Chinese cohorts reveals similarities and differences compared to Western populations.
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug Carrier.
Predicting Survival in Patients with Neuroendocrine Prostate Cancer: A SEER-Based Comprehensive Study.
Correction: TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination.
Rising Prevalence of Urinary Incontinence and Nocturia Amid the COVID-19 Pandemic.
Reinforcement Learning–Based Digital Therapeutic Intervention for Postprostatectomy Incontinence: Development and Pilot Feasibility Study (Preprint)
Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3.
Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis
Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis
Low-dimensional antimicrobial nanomaterials in anti-infection treatment and wound healing
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression.
Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer
SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
Correction: Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer
Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.